Sector
PharmaceuticalsOpen
₹845.5Prev. Close
₹842.8Turnover(Lac.)
₹50.42Day's High
₹862.95Day's Low
₹831.1552 Week's High
₹1,753.9552 Week's Low
₹762.6Book Value
₹700.85Face Value
₹10Mkt Cap (₹ Cr.)
476.76P/E
27.82EPS
30.12Divi. Yield
0.6Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.71 | 5.71 | 5.71 | 5.71 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 377.27 | 305.87 | 273.76 | 238.67 |
Net Worth | 382.98 | 311.58 | 279.47 | 244.38 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Revenue | 320.79 | 287.45 | 295.32 | 322.6 |
yoy growth (%) | 11.59 | -2.66 | -8.45 | 0.25 |
Raw materials | -105.39 | -90.93 | -85.04 | -94.68 |
As % of sales | 32.85 | 31.63 | 28.79 | 29.35 |
Employee costs | -90.33 | -84.53 | -83.17 | -81.6 |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Profit before tax | 28.95 | 21.54 | 27.23 | 22.21 |
Depreciation | -7.67 | -8.23 | -7.51 | -8.99 |
Tax paid | -9.78 | -8.06 | -10.17 | -15.02 |
Working capital | -38.2 | -2.63 | -1.62 | 8.15 |
Other operating items |
Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 11.59 | -2.66 | -8.45 | 0.25 |
Op profit growth | 39.53 | -22.03 | -10.27 | -15.11 |
EBIT growth | 32.79 | -19.91 | 16.44 | 4.6 |
Net profit growth | 94.78 | -38.32 | -66.75 | 250.32 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
A K Kothari
Non Executive Director
Prabhawati Devi Kothari
Independent Director
Monjori Mitra
Non Executive Director
Anand Vardhan Kothari
Managing Director & CEO
U. M. Kunte
Independent Director
Anurag Singhi
Independent Director
Shourya Sengupta
D Block 3rd Flr Gillander Hous,
Netaji Subhas Road,
West Bengal - 700001
Tel: 91-33-22302330/2262 8436/8456/
Website: http://www.albertdavidindia.com
Email: [email protected]; [email protected]
23 RN Mukherjee Road,
5th Floor,
Kolkata-700001
Tel: 91-33-22435029/22482
Website: www.mdpl.in
Email: [email protected]
Summary
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal busi...
Read More
Reports by Albert David Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.